Refinement and preliminary evaluation of two tablet-based tests of real-world visual function [PDF]
, 2019 PURPOSE: To describe, refine, evaluate, and provide normative control data for two freely available tablet-based tests of real-world visual function, using a cohort of young, normally-sighted adults.
Bi, W. +6 more
core +2 more sources
Cyclophotocoagulation with diode laser in refractory glaucoma, long-term results [PDF]
, 2003 PURPOSE: To report long-term experience with cyclophotocoagulation using diode laser in refractory glaucomas. METHODS: We selected cases of refractory glaucoma with indication for cyclophotocoagulation (CPC) with diode laser using a G probe (Iris Medical)
Lima, Vera Christina Waller de +2 more
core +3 more sources
Modified Schocket implant for refractory glaucoma: long-term results [PDF]
, 2000 Purpose: To analyze long-term results of modified Schocket implant. Methods: The records of 45 patients (45 surgeries) with at least one year follow-up who received a modified Schocket implant were analyzed. Comparisons were made regarding success rates (
Omi, Carlos Akira +2 more
core +3 more sources
Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. [PDF]
, 2013 BACKGROUND: Diseases of the posterior segment of the eye, including age-related macular degeneration (AMD), have recently been recognised as the leading or second leading cause of blindness in several African countries.
Bastawrous, Andrew +5 more
core +6 more sources
Longer-term Baerveldt to Trabectome glaucoma surgery comparison using propensity score matching [PDF]
, 2017 Purpose: To apply propensity score matching to compare Baerveldt glaucoma drainage implant (BGI) to Trabectome-mediated ab interno trabeculectomy (AIT). Recent data suggests that AIT can produce results similar to BGI which is traditionally reserved for ...
Brown, EN +6 more
core +1 more source
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma [PDF]
, 2016 The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the beginning of a new era in the management of several sight-threatening ...
Andrés Guerrero, Vanessa +9 more
core +4 more sources
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review [PDF]
, 2017 The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor (VEGF) injections on intraocular pressure have not been fully characterized, and the development of sustained ocular hypertension could adversely affect ...
Bracha, Peter +4 more
core +1 more source
Novel Retinal Imaging Technologies [PDF]
, 2017 Newly-developed imaging techniques show extensive promise and potential to improve early detection, accurate diagnosis, and management of retinal diseases.
Li Y, Xia X, Paulus YM
core +1 more source
Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules [PDF]
, 2019 The present review focuses on recent clinical trials that analyze the efficacy of intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD), such as neuroprotective drugs, and complement inhibitors, also called ...
Cerini, Alberto +5 more
core +1 more source
Matrix Metalloproteinases and Glaucoma Treatment. [PDF]
, 2020 Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade extracellular matrix (ECM) components such as collagen and have important roles in multiple biological processes, including development and tissue remodeling, both in ...
Dibas, Mohammed +3 more
core